132 related articles for article (PubMed ID: 9158023)
21. Hepatitis C virus-related proteins in kidney tissue from hepatitis C virus-infected patients with cryoglobulinemic membranoproliferative glomerulonephritis.
Sansonno D; Gesualdo L; Manno C; Schena FP; Dammacco F
Hepatology; 1997 May; 25(5):1237-44. PubMed ID: 9141444
[TBL] [Abstract][Full Text] [Related]
22. Treatment of progressive hepatitis C recurrence after liver transplantation with combination interferon plus ribavirin.
Gopal DV; Rabkin JM; Berk BS; Corless CL; Chou S; Olyaei A; Orloff SL; Rosen HR
Liver Transpl; 2001 Mar; 7(3):181-90. PubMed ID: 11244158
[TBL] [Abstract][Full Text] [Related]
23. Factors influencing renal function after liver transplantation. Results from the MOST, an international observational study.
Burra P; Senzolo M; Masier A; Prestele H; Jones R; Samuel D; Villamil F
Dig Liver Dis; 2009 May; 41(5):350-6. PubMed ID: 19046932
[TBL] [Abstract][Full Text] [Related]
24. The long-term effects of immune suppression on liver transplant recipients with recurrent hepatitis C viral infection.
Neff GW; delaGarza J; Shire N; Nishida S; O'Brien CB; Safdar K; Madariaga J; Schiff E; Ruiz P
Transplant Proc; 2004 Dec; 36(10):3065-7. PubMed ID: 15686695
[TBL] [Abstract][Full Text] [Related]
25. Progressive renal failure and blindness due to retinal hemorrhage after interferon therapy for hepatitis C virus-associated membranoproliferative glomerulonephritis.
Suzuki T; Yonemura K; Miyaji T; Suzuki H; Takahira R; Fujigaki Y; Fujimoto T; Hishida A
Intern Med; 2001 Aug; 40(8):708-12. PubMed ID: 11518107
[TBL] [Abstract][Full Text] [Related]
26. Pretransplant interferon prevents hepatitis C virus-associated glomerulonephritis in renal allografts by HCV-RNA clearance.
Cruzado JM; Casanovas-Taltavull T; Torras J; Baliellas C; Gil-Vernet S; Grinyó JM
Am J Transplant; 2003 Mar; 3(3):357-60. PubMed ID: 12614294
[TBL] [Abstract][Full Text] [Related]
27. Clinical course of hepatitis C virus infection in renal transplant recipients.
Savas N; Ocal S; Colak T; Karakayali H; Yilmaz U; Haberal M
Transplant Proc; 2007 May; 39(4):984-6. PubMed ID: 17524869
[TBL] [Abstract][Full Text] [Related]
28. Development of hepatic granulomas in patients receiving pegylated interferon therapy for recurrent hepatitis C virus post liver transplantation.
Fiel MI; Shukla D; Saraf N; Xu R; Schiano TD
Transpl Infect Dis; 2008 Jun; 10(3):184-9. PubMed ID: 17916116
[TBL] [Abstract][Full Text] [Related]
29. Daclatasvir/asunaprevir based direct-acting antiviral therapy ameliorate hepatitis C virus-associated cryoglobulinemic membranoproliferative glomerulonephritis: a case report.
Shimada M; Nakamura N; Endo T; Yamabe H; Nakamura M; Murakami R; Narita I; Tomita H
BMC Nephrol; 2017 Mar; 18(1):109. PubMed ID: 28356063
[TBL] [Abstract][Full Text] [Related]
30. Glomerular disease during HCV infection in renal transplantation.
Hammoud H; Haem J; Laurent B; Alamartine E; Diab N; Defilippis JP; Berthoux P; Berthoux F
Nephrol Dial Transplant; 1996; 11 Suppl 4():54-5. PubMed ID: 8918756
[TBL] [Abstract][Full Text] [Related]
31. Effect of combination therapy (ribavirin and interferon) in HCV-related glomerulopathy.
Sabry AA; Sobh MA; Sheaashaa HA; Kudesia G; Wild G; Fox S; Wagner BE; Irving WL; Grabowska A; El-Nahas AM
Nephrol Dial Transplant; 2002 Nov; 17(11):1924-30. PubMed ID: 12401848
[TBL] [Abstract][Full Text] [Related]
32. Treatment of established recurrent hepatitis C in liver-transplant recipients with pegylated interferon-alfa-2b and ribavirin therapy.
Neff GW; Montalbano M; O'Brien CB; Nishida S; Safdar K; Bejarano PA; Khaled AS; Ruiz P; Slapak-Green G; Lee M; Nery J; De Medina M; Tzakis A; Schiff ER
Transplantation; 2004 Nov; 78(9):1303-7. PubMed ID: 15548967
[TBL] [Abstract][Full Text] [Related]
33. The high prevalence of severe early posttransplant renal allograft pathology in hepatitis C positive recipients.
Cosio FG; Sedmak DD; Henry ML; Al Haddad C; Falkenhain ME; Elkhammas EA; Davies EA; Bumgardner GL; Ferguson RM
Transplantation; 1996 Oct; 62(8):1054-9. PubMed ID: 8900300
[TBL] [Abstract][Full Text] [Related]
34. Renal manifestations of hepatitis C virus infection. Extrahepatic complications often are silent--and thus overlooked.
Bandi L
Postgrad Med; 2003 Feb; 113(2):73-6, 86. PubMed ID: 12611116
[TBL] [Abstract][Full Text] [Related]
35. Response to high-dose interferon-alpha after failure of standard therapy in MPGN associated with hepatitis C virus infection.
Sarac E; Bastacky S; Johnson JP
Am J Kidney Dis; 1997 Jul; 30(1):113-5. PubMed ID: 9214409
[TBL] [Abstract][Full Text] [Related]
36. Successful treatment of donor-derived hepatitis C viral infection in three transplant recipients from a donor at increased risk for bloodborne pathogens.
Shah AP; Cameron A; Singh P; Frank AM; Fenkel JM
Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28060446
[TBL] [Abstract][Full Text] [Related]
37. Treatment of chronic hepatitis C with recombinant interferon alpha in kidney transplant recipients.
Rostaing L; Izopet J; Baron E; Duffaut M; Puel J; Durand D
Transplantation; 1995 May; 59(10):1426-31. PubMed ID: 7770930
[TBL] [Abstract][Full Text] [Related]
38. Glomerular diseases in patients with hepatitis C virus infection after renal transplantation.
Morales JM; Campistol JM; Andrés A; Rodicio JL
Curr Opin Nephrol Hypertens; 1997 Nov; 6(6):511-5. PubMed ID: 9375261
[TBL] [Abstract][Full Text] [Related]
39. Fibrosing cholestatic hepatitis in renal transplant recipients with hepatitis C virus infection.
Delladetsima JK; Boletis JN; Makris F; Psichogiou M; Kostakis A; Hatzakis A
Liver Transpl Surg; 1999 Jul; 5(4):294-300. PubMed ID: 10388502
[TBL] [Abstract][Full Text] [Related]
40. [A case of membranoproliferative glomerulonephritis due to type II cryoglobulinemia probably associated with hepatitis C virus infection].
Ikeda Y; Nakano H; Sakemi T; Nagano Y; Otsuka N; Baba N; Syouno Y; Yamaguchi K
Nihon Jinzo Gakkai Shi; 1994 Mar; 36(3):284-8. PubMed ID: 8196226
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
